GPX3 is targeted and downregulated by miR-196a which is overexpressed in non-small-cell lung carcinoma (NSCLC) cancers, leading to attenuation of tumorigenicity and cancer cell growth through upregulation of GPX3. This evidence concerns the gene GPX3 and non-small cell lung carcinoma.